Skip to main content
. 2019 Oct 9;19(4):329–338. doi: 10.1007/s40268-019-00284-1
In the atopic dermatitis (AD) epidermis, phosphodiesterase (PDE) 4 isoform expression is increased up to three-fold compared with healthy skin.
PDE4 inhibition with apremilast significantly changed messenger RNA expression of several interleukins (ILs), alarmins, and small proline-rich protein, in IL-4- and IL-17-stimulated adult human epidermal keratinocyte cells.
In mouse models of AD, apremilast significantly reduced ear swelling and monocyte chemoattractant protein-1 protein expression.
Results highlight the potential direct effects and limitations of PDE4 inhibition on keratinocyte responses in AD.